Takeda Adds Theravance GI Candidate In Deal Flurry
In its third licensing deal this week, Takeda is allying with Theravance for the global development of a gastrointestinal agent that will bolster its core portfolio in this area.
In its third licensing deal this week, Takeda is allying with Theravance for the global development of a gastrointestinal agent that will bolster its core portfolio in this area.